The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122899762 12289976 2 F 20150420 20160708 20160421 20160713 EXP DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-020153 BRISTOL MYERS SQUIBB 51.94 YR M Y 90.00000 KG 20160713 CN DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122899762 12289976 1 PS DACLATASVIR DIHYDROCHLORIDE DACLATASVIR DIHYDROCHLORIDE 1 Oral 60 MG, QD 10080 MG Y 206843 60 MG QD
122899762 12289976 2 SS SOFOSBUVIR SOFOSBUVIR 1 Oral 400 MG, UNK Y 0 400 MG QD
122899762 12289976 3 SS RIBAVIRIN. RIBAVIRIN 1 Oral 1200 MG, UNK Y 0 1200 MG QD
122899762 12289976 4 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 Unknown U 0
122899762 12289976 5 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 1500 MG, UNK U 0 1500 MG
122899762 12289976 6 C HUMALOG INSULIN LISPRO 1 Unknown U 0
122899762 12289976 7 C PROTAPHANE INSULIN HUMAN 1 Unknown U 0
122899762 12289976 8 C RAMIPRIL. RAMIPRIL 1 Unknown UNK U 0
122899762 12289976 9 C ZOLPIDEM ZOLPIDEMOLPIDEM TARTRATE 1 Unknown UNK, PRN U 0
122899762 12289976 10 C CANDESARTAN CANDESARTAN 1 Unknown 8 MG, UNK U 0 8 MG
122899762 12289976 11 C SPIRONOLACTONE. SPIRONOLACTONE 1 Unknown 100 MG, UNK U 0 100 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122899762 12289976 1 Chronic hepatitis C
122899762 12289976 2 Chronic hepatitis C
122899762 12289976 3 Chronic hepatitis C
122899762 12289976 4 Product used for unknown indication
122899762 12289976 5 Product used for unknown indication
122899762 12289976 6 Product used for unknown indication
122899762 12289976 7 Product used for unknown indication
122899762 12289976 8 Product used for unknown indication
122899762 12289976 9 Product used for unknown indication
122899762 12289976 10 Cardiovascular disorder
122899762 12289976 11 Cardiovascular disorder

Outcome of event

Event ID CASEID OUTC COD
122899762 12289976 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122899762 12289976 Arthralgia
122899762 12289976 Blood urine present
122899762 12289976 Chest pain
122899762 12289976 Decreased appetite
122899762 12289976 Depressed mood
122899762 12289976 Dizziness
122899762 12289976 Fatigue
122899762 12289976 Hypertensive crisis
122899762 12289976 Mitral valve incompetence
122899762 12289976 Mood altered
122899762 12289976 Tricuspid valve incompetence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122899762 12289976 1 20150316 20150830 0
122899762 12289976 2 20150316 20150830 0
122899762 12289976 3 20150316 20150830 0
122899762 12289976 11 20160128 0